Fibrinogen-to-Albumin Ratio in Familial Mediterranean Fever: Association with Subclinical Inflammation
暂无分享,去创建一个
[1] Binbin Cui,et al. Research Progress of Preoperative FPR, FAR or AFR in Patients with Colorectal Cancer , 2021, Cancer management and research.
[2] G. Yan,et al. Relation of Fibrinogen-to-Albumin Ratio to Severity of Coronary Artery Disease and Long-Term Prognosis in Patients with Non-ST Elevation Acute Coronary Syndrome , 2020, BioMed research international.
[3] H. Marzouk,et al. Red Cell Distribution Width (RDW) as a marker of Subclinical Inflammation in Children with Familial Mediterranean Fever. , 2020, Current rheumatology reviews.
[4] Zhengping Huang,et al. The role of fibrinogen to albumin ratio in ankylosing spondylitis: Correlation with disease activity. , 2020, Clinica chimica acta; international journal of clinical chemistry.
[5] R. Cimaz,et al. Periodic fever syndromes and the autoinflammatory diseases (AIDs) , 2019, Journal of translational autoimmunity.
[6] I. Mitroulis,et al. Autoinflammation: Lessons from the study of familial Mediterranean fever. , 2019, Journal of autoimmunity.
[7] B. Goker,et al. Chronic inflammation in adult familial Mediterranean fever patients: underlying causes and association with amyloidosis , 2019, Scandinavian journal of rheumatology.
[8] J. Luyendyk,et al. The multifaceted role of fibrinogen in tissue injury and inflammation. , 2019, Blood.
[9] H. Ozdogan,et al. Familial Mediterranean Fever. , 2019, Presse medicale.
[10] Alaaddin Yorulmaz,et al. Evaluation of hematological parameters in children with FMF , 2018, Clinical rheumatology.
[11] Q. Ou,et al. Correlation between albumin to fibrinogen ratio, C-reactive protein to albumin ratio and Th17 cells in patients with rheumatoid arthritis. , 2019, Clinica chimica acta; international journal of clinical chemistry.
[12] J. Braun,et al. Evidenzbasierte Therapieempfehlungen für das familiäre Mittelmeerfieber , 2019, Zeitschrift für Rheumatologie.
[13] D. Foell,et al. The role of S100 proteins in the pathogenesis and monitoring of autoinflammatory diseases , 2018, Molecular and Cellular Pediatrics.
[14] K. Mao,et al. A Novel Inflammation-Based Prognostic Score: The Fibrinogen/Albumin Ratio Predicts Prognoses of Patients after Curative Resection for Hepatocellular Carcinoma , 2018, Journal of immunology research.
[15] P. Brož,et al. Function and mechanism of the pyrin inflammasome , 2018, European journal of immunology.
[16] M. Otagiri,et al. Clinical Implications Associated With the Posttranslational Modification-Induced Functional Impairment of Albumin in Oxidative Stress-Related Diseases. , 2017, Journal of pharmaceutical sciences.
[17] N. Çakar,et al. Assessment of neutrophil to lymphocyte ratio and mean platelet volume in pediatric familial Mediterranean fever patients , 2017, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.
[18] Y. Yilmaz,et al. Evaluation of subclinical inflammation in familial Mediterranean fever patients: relations with mutation types and attack status: a retrospective study , 2016, Clinical Rheumatology.
[19] D. Kastner,et al. EULAR recommendations for the management of familial Mediterranean fever , 2016, Annals of the rheumatic diseases.
[20] D. Foell,et al. Increased serum concentrations of neutrophil-derived protein S100A12 in heterozygous carriers of MEFV mutations. , 2015, Clinical and experimental rheumatology.
[21] D. Karabel,et al. Assessment of epicardial adipose tissue thickness and the mean platelet volume in children with familial Mediterranean fever , 2015, Italian Journal of Pediatrics.
[22] E. Bora,et al. Risk factors for subclinical inflammation in children with Familial Mediterranean fever , 2015, Rheumatology International.
[23] E. Sönmezgöz,et al. Simple Markers for Subclinical Inflammation in Patients with Familial Mediterranean Fever , 2015, Medical science monitor : international medical journal of experimental and clinical research.
[24] S. Moiseev,et al. Predictors of AA amyloidosis in familial Mediterranean fever , 2015, Rheumatology International.
[25] M. Uysal,et al. As a New Inflammatory Marker for Familial Mediterranean Fever: Neutrophil-to-Lymphocyte Ratio , 2013, Inflammation.
[26] S. Kelekçi,et al. Comparison of acute phase response during attack and attack-free period in children with Familial Mediterranean Fever , 2013 .
[27] I. Ben-Zvi,et al. Chronic inflammation in FMF: markers, risk factors, outcomes and therapy , 2011, Nature Reviews Rheumatology.
[28] D. Booth,et al. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. , 2006, Rheumatology.
[29] A. Bakkaloğlu. Familial Mediterranean fever , 2003, Pediatric Nephrology.
[30] S. Akıncı,et al. Serum sIL-2r, IL-6, IL-10 and TNF-α level in familial Mediterranean fever patients , 2003, Clinical Rheumatology.
[31] S. Akıncı,et al. Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients. , 2003, Clinical rheumatology.
[32] H. Yazici,et al. Acute phase response in familial Mediterranean fever , 2002, Annals of the rheumatic diseases.
[33] D. Zemer,et al. Activation of the cytokine network in familial Mediterranean fever. , 1999, The Journal of rheumatology.
[34] M. Ehrenfeld,et al. Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. , 1999, American journal of medical genetics.
[35] E. Ben-Chetrit,et al. Familial Mediterranean fever , 1998, The Lancet.
[36] M. Pras,et al. Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. , 1998, American journal of medical genetics.
[37] E. Sohar,et al. FAMILIAL MEDITERRANEAN FEVER , 1959, Definitions.